Kolexia
Ferreira Joao Pedro Médecine interne
Ferreira Joao Pedro
Médecine interne
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
361 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Défaillance cardiaque Diabète de type 2 Infarctus du myocarde Infarctus Diabète Dysfonction ventriculaire gauche Albuminurie Hypertension artérielle Accident vasculaire cérébral

Collaborateurs

Voir plus
Zannad Faiez
Zannad Faiez
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Rossignol Patrick
Rossignol Patrick
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Girerd Nicolas
Girerd Nicolas
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Boivin Jean-Marc
Boivin Jean-Marc
Cabinet libéral, Laxou, France

Industries

Voir plus
Boehringer Ingelheim
2 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.
European journal of heart failure   04 mars 2024
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis.
European journal of heart failure   04 mars 2024
Is Reducing Heart Failure Hospitalization Associated With Reducing Mortality in Heart Failure Trials?
JACC. Heart failure   27 février 2024
SELECT - Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
Essai Clinique (Novo Nordisk)   13 février 2024
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT.
International journal of cardiology   01 février 2024
Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study.
Atherosclerosis   24 janvier 2024
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved.
European journal of heart failure   21 janvier 2024
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
Journal of cachexia, sarcopenia and muscle   29 décembre 2023
High risk of stroke in patients with worsening heart failure, reduced ejection fraction, coronary heart disease and sinus rhythm: Risk prediction score analysis from the COMMANDER-HF trial.
Journal of cardiac failure   18 décembre 2023
Risk of readmission and death after hospitalization for worsening heart failure: Role of post-discharge follow-up visits in a real-world study from the Grand Est Region of France.
European journal of heart failure   07 décembre 2023